Most Read Articles
2 days ago
No association exists between physical activity and the risk of urological cancer, according to a population-based prospective study in Japan.
12 Feb 2019
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
3 days ago
Patients with childhood-onset inflammatory bowel disease are more likely to die than the general population, a study suggests.
3 days ago
Reduced caloric intake results in a significant improvement in glucose metabolism and body-fat composition, including liver-fat content, according to a study. Changes in ferritin levels appear to mediate the striking reduction in liver fat.

Sarilumab shows promise in treatment of noninfectious uveitis of posterior segment

08 Nov 2018

Subcutaneous sarilumab shows therapeutic potential in the management of noninfectious uveitis affecting the posterior segment of the eye, especially eyes with uveitic macular oedema, according to the results of the phase II SATURN trial.

SATURN randomly assigned (2:1) 58 eyes of adult patients with noninfectious intermediate, posterior or panuveitis to treatment with subcutaneous sarilumab 200 mg or placebo administered every other day for 16 weeks.

At week 16, the primary endpoint of proportion of patients with ≥2-step reduction in vitreous haze (VH) did not significantly differ between the sarilumab and placebo arms (mean, 46.1 percent vs 30.0 percent; p=0.2354). The alternate primary endpoint of corticosteroid dose <10 mg/day was better in the former arm (mean, 64.0 percent vs 35.0 percent; p=0.0372).

In the subgroup of eyes VH grade 2 or higher at baseline, VH decreased significantly with sarilumab vs placebo at week 16 regardless of assessment by central reading centre (mean, –2.1 vs –1.7; p=0.0255) or investigator (–2.5 vs –1.2; p=0.0170).

Sarilumab was also superior to placebo in terms of mean best-corrected visual acuity gain from baseline to week 16 in the overall population (8.9 vs 3.6 letters; p=0.0333) and in the subgroup of eyes with central subfield thickness (CST) ≥300 μm at baseline (12.2 vs 2.1 letters; p=0.0517). Corresponding changes in CST were –46.8 vs 2.6 μm (p=0.0683) in the overall population and –112.5 vs –1.8 μm (p=0.1317) in the subgroup of eyes with CST ≥300 μm at baseline, respectively.

Commonly reported ocular adverse events included worsening of uveitis and retinal infiltrates.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
No association exists between physical activity and the risk of urological cancer, according to a population-based prospective study in Japan.
12 Feb 2019
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
3 days ago
Patients with childhood-onset inflammatory bowel disease are more likely to die than the general population, a study suggests.
3 days ago
Reduced caloric intake results in a significant improvement in glucose metabolism and body-fat composition, including liver-fat content, according to a study. Changes in ferritin levels appear to mediate the striking reduction in liver fat.